203 related articles for article (PubMed ID: 31070486)
1. Anti-aging formulation of rosmarinic acid-loaded ethosomes and liposomes.
Yücel Ç; Şeker Karatoprak G; Değim İT
J Microencapsul; 2019 Mar; 36(2):180-191. PubMed ID: 31070486
[TBL] [Abstract][Full Text] [Related]
2. Development and characterization of a novel antiacne niosomal gel of rosmarinic acid.
Budhiraja A; Dhingra G
Drug Deliv; 2015; 22(6):723-30. PubMed ID: 24786487
[TBL] [Abstract][Full Text] [Related]
3. Melatonin loaded ethanolic liposomes: physicochemical characterization and enhanced transdermal delivery.
Dubey V; Mishra D; Jain NK
Eur J Pharm Biopharm; 2007 Sep; 67(2):398-405. PubMed ID: 17452098
[TBL] [Abstract][Full Text] [Related]
4. Dermal and transdermal delivery of an anti-psoriatic agent via ethanolic liposomes.
Dubey V; Mishra D; Dutta T; Nahar M; Saraf DK; Jain NK
J Control Release; 2007 Nov; 123(2):148-54. PubMed ID: 17884226
[TBL] [Abstract][Full Text] [Related]
5. Release of rosmarinic acid from semisolid formulations and its penetration through human skin ex vivo.
Stelmakienė A; Ramanauskienė K; Briedis V
Acta Pharm; 2015 Jun; 65(2):199-205. PubMed ID: 26011936
[TBL] [Abstract][Full Text] [Related]
6. Development, characterization, and skin delivery studies of related ultradeformable vesicles: transfersomes, ethosomes, and transethosomes.
Ascenso A; Raposo S; Batista C; Cardoso P; Mendes T; Praça FG; Bentley MV; Simões S
Int J Nanomedicine; 2015; 10():5837-51. PubMed ID: 26425085
[TBL] [Abstract][Full Text] [Related]
7. Ethosomal (-)-epigallocatechin-3-gallate as a novel approach to enhance antioxidant, anti-collagenase and anti-elastase effects.
Yücel Ç; Şeker Karatoprak G; Yalçıntaş S; Eren Böncü T
Beilstein J Nanotechnol; 2022; 13():491-502. PubMed ID: 35707628
[TBL] [Abstract][Full Text] [Related]
8. Development, characterization and nasal delivery of rosmarinic acid-loaded solid lipid nanoparticles for the effective management of Huntington's disease.
Bhatt R; Singh D; Prakash A; Mishra N
Drug Deliv; 2015; 22(7):931-9. PubMed ID: 24512295
[TBL] [Abstract][Full Text] [Related]
9. Development, physico-chemical characterization and in-vitro studies of hydrogels containing rosmarinic acid-loaded nanoemulsion for topical application.
Marafon P; Fachel FNS; Dal Prá M; Bassani VL; Koester LS; Henriques AT; Braganhol E; Teixeira HF
J Pharm Pharmacol; 2019 Aug; 71(8):1199-1208. PubMed ID: 31124591
[TBL] [Abstract][Full Text] [Related]
10. Development of stable tocopherol succinate-loaded ethosomes to enhance transdermal permeation: In vitro and in vivo characterizations.
Akhtar N; Akhtar N
J Cosmet Dermatol; 2022 Oct; 21(10):4942-4955. PubMed ID: 35274433
[TBL] [Abstract][Full Text] [Related]
11. Preparation and In Vivo Evaluation of Rosmarinic Acid-Loaded Transethosomes After Percutaneous Application on a Psoriasis Animal Model.
Rodríguez-Luna A; Talero E; Ávila-Román J; Romero AMF; Rabasco AM; Motilva V; González-Rodríguez ML
AAPS PharmSciTech; 2021 Mar; 22(3):103. PubMed ID: 33712964
[TBL] [Abstract][Full Text] [Related]
12. An evaluation of tocotrienol ethosomes for transdermal delivery using Strat-M
Nair RS; Billa N; Leong CO; Morris AP
Pharm Dev Technol; 2021 Feb; 26(2):243-251. PubMed ID: 33274672
[TBL] [Abstract][Full Text] [Related]
13. In vitro percutaneous permeation and skin accumulation of finasteride using vesicular ethosomal carriers.
Rao Y; Zheng F; Zhang X; Gao J; Liang W
AAPS PharmSciTech; 2008; 9(3):860-5. PubMed ID: 18649143
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of transdermal permeation promotion of lipophilic drugs by ethosomes.
Yang L; Wu L; Wu D; Shi D; Wang T; Zhu X
Int J Nanomedicine; 2017; 12():3357-3364. PubMed ID: 28490875
[TBL] [Abstract][Full Text] [Related]
15. Enhanced transdermal bioavailability of testosterone propionate via surfactant-modified ethosomes.
Meng S; Chen Z; Yang L; Zhang W; Liu D; Guo J; Guan Y; Li J
Int J Nanomedicine; 2013; 8():3051-60. PubMed ID: 23990718
[TBL] [Abstract][Full Text] [Related]
16. Combinations of nanovesicles and physical methods for enhanced transdermal delivery of a model hydrophilic drug.
Zorec B; Zupančič Š; Kristl J; Pavšelj N
Eur J Pharm Biopharm; 2018 Jun; 127():387-397. PubMed ID: 29581043
[TBL] [Abstract][Full Text] [Related]
17. Formulation and Characterization of Nanosized Ethosomal Formulations of Antigout Model Drug (Febuxostat) Prepared by Cold Method: In Vitro/Ex Vivo and In Vivo Assessment.
El-Shenawy AA; Abdelhafez WA; Ismail A; Kassem AA
AAPS PharmSciTech; 2019 Dec; 21(1):31. PubMed ID: 31858305
[TBL] [Abstract][Full Text] [Related]
18. Transdermal delivery of raloxifene HCl via ethosomal system: Formulation, advanced characterizations and pharmacokinetic evaluation.
Mahmood S; Mandal UK; Chatterjee B
Int J Pharm; 2018 May; 542(1-2):36-46. PubMed ID: 29501737
[TBL] [Abstract][Full Text] [Related]
19. Dual functional liposomes carrying antioxidants against tau hyperphosphorylation and apoptosis of neurons.
Kuo YC; Lou YI; Rajesh R
J Drug Target; 2020 Nov; 28(9):949-960. PubMed ID: 32338078
[TBL] [Abstract][Full Text] [Related]
20. Transdermal glimepiride delivery system based on optimized ethosomal nano-vesicles: Preparation, characterization, in vitro, ex vivo and clinical evaluation.
Ahmed TA; El-Say KM; Aljaeid BM; Fahmy UA; Abd-Allah FI
Int J Pharm; 2016 Mar; 500(1-2):245-54. PubMed ID: 26775063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
